Literature DB >> 25457884

Risk factors for and consequences of inadequate surgical margins in oral squamous cell carcinoma.

Mads Lawaetz1, Preben Homøe2.   

Abstract

OBJECTIVE: The purpose of this study was to examine which factors are associated with inadequate surgical margins and to assess the postoperative consequences. STUDY
DESIGN: A retrospective cohort of 110 patients with oral squamous cell carcinoma treated with surgery during a 2-year period was examined. Clinical, histopathologic, and operative variables were related to the surgical margin status. Furthermore postoperative treatment data were compared with margin status.
RESULTS: Univariate statistically significant associations were found between the tumor site in the floor of mouth, more advanced T-stage, increasing tumor thickness, and inadequate margins. Of the patients with involved margins, 87% were treated with postoperative radiotherapy or re-resection, but among patients with close margins, only 35% received either radiotherapy or re-resection.
CONCLUSIONS: Clinical and histopathologic factors were associated with the inadequate margin. Postoperative treatment for patients with close margins is controversial, and more studies are needed to define clear guidelines.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25457884     DOI: 10.1016/j.oooo.2014.08.001

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  2 in total

1.  CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma.

Authors:  Zhen-Hu Ren; Yong-Xiang Yuan; Tong Ji; Chen-Ping Zhang
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

2.  Vibroacoustographic System for Tumor Identification.

Authors:  Peter A Pellionisz; Nikan K Namiri; Gregory Suematsu; Yong Hu; Ameet Braganza; Khuzaima Rangwalla; Daniel J Denson; Karam Badran; Nathan C Francis; Ashkan Maccabi; George Saddik; Zachary Taylor; Maie A St John; Warren S Grundfest
Journal:  Yale J Biol Med       Date:  2018-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.